Nicola Pemberton MD Fights to Serve Women in New Jersey and Abroad: A Hero to Many

Nicola Pemberton MD, FACOG is a heroine of New Jersey. Not only has she delivered over 50 babies since the COVID-19 pandemic started, she delivered five babies within 24 hours a few days ago on June 17, 2020. The news was announced by the Birth Center of New Jersey.

Throughout the entire pandemic, she has served hundreds of women via telemedicine and office visits, calming their fears and anxieties throughout these stressful times. She wears double masks at all times while she delivers these babies.

Nicola Pemberton MD fights the dismal statistics in racial disparities in maternal mortality for black women in New Jersey every day. Earlier this year, she was featured on “Sex: Explained (Child Birth)”, where Vox actually filmed a birth with her as the doctor attending the birth. She is the medical director for The Birth Center of New Jersey. She works tirelessly to help lower the C-Section rate in New Jersey, which is currently the highest in the nation.

Women would love to know about a doctor and her team that holds their health as a number one priority. Women are curious about water births performed at The Birth Center of New Jersey. Dr. Pemberton founded the Birth Center of New Jersey to give women natural birthing options. She has been serving women, her entire career and deserves to be recognized.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”